- Non-invasive molecular imaging of immune cell dynamics for vaccine research
-
Youn H, Hong KJ
- KMID: 2455079
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):89-93.
- doi: 10.7774/cevr.2019.8.2.89
In order to develop a successful vaccine against deadly diseases with a wide range of antigenic diversity, an in-depth knowledge of the molecules and signaling mechanisms between the vaccine candidates... -
- CITED
-
- Close
- SHARE
-
- Close
- Rabies immune status of raccoon dogs residing in areas where rabies bait vaccine has been distributed
-
Yang DK, Kim HH, Lee EJ, Yoo JY, Kim JT, Ahn S
- KMID: 2455085
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):132-135.
- doi: 10.7774/cevr.2019.8.2.132
Since 2000, large amounts of rabies bait vaccine have been distributed in two provinces where raccoon dog-mediated rabies has occurred. A total of 146 raccoon dogs were caught in Gangwon... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of simultaneous administration of foot-and-mouth disease (FMD) and anthrax vaccines on antibody response to FMD in sheep
-
Çokçalışkan C, Tuncer Göktuna P, Türkoğlu T, Uzunlu E, Gündüzalp C, Uzun EA, Sareyyüpoğlu B, Kürkçü , Gülyaz V
- KMID: 2455081
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):103-109.
- doi: 10.7774/cevr.2019.8.2.103
PURPOSE: Foot-and-mouth disease (FMD) and anthrax are important diseases in sheep. Vaccination is a favorable strategy against both infections. Simultaneous administration of vaccines does generally not impede the immune responses... -
- CITED
-
- Close
- SHARE
-
- Close
- Plant factory: new resource for the productivity and diversity of human and veterinary vaccines
-
Shim BS, Hong KJ, Maharjan P, Choe S
- KMID: 2455086
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):136-139.
- doi: 10.7774/cevr.2019.8.2.136
Vaccination is one of the most successful strategies to prevent diseases caused by pathogens. Although various expression systems including Escherichia coli, yeast, insect, and mammalian cells are currently used for... -
- CITED
-
- Close
- SHARE
-
- Close
- A meningococcal B vaccine induces cross-protection against gonorrhea
-
Azze RF
- KMID: 2455082
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):110-115.
- doi: 10.7774/cevr.2019.8.2.110
PURPOSE: Neisseria meningitidis and Neisseria gonorrhoeae share between 80% and 90% of their genetic sequence. Meningococcal serogroup B vaccines based on outer membrane vesicles—such as VA-MENGOC-BC—could cross-protect against gonorrhea. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Transient expression of hemagglutinin antigen from canine influenza virus H3N2 in Nicotiana benthamiana and Lactuca sativa
-
Maharjan P, Choe S
- KMID: 2455084
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):124-131.
- doi: 10.7774/cevr.2019.8.2.124
PURPOSE: Canine influenza virus (CIV), H3N2, carries potentiality for zoonotic transmission and genetic assortment which raises a concern on possible epidemics, and human threats in future. To manage possible threats,... -
- CITED
-
- Close
- SHARE
-
- Close
- A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children
-
Hwang JH, Kim KH, Han SB, Kim HH, Kim JH, Lee SY, Choi UY, Kang JH
- KMID: 2455083
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):116-123.
- doi: 10.7774/cevr.2019.8.2.116
PURPOSE: There are limited population-based data regarding herpes zoster in children. Thus we conducted a multi-institutional epidemiological analysis of herpes zoster in children and comparative analysis according to their immune... -
- CITED
-
- Close
- SHARE
-
- Close
- One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea
-
Lee HJ, Jo DS, Kim YK, Lee H, Kim KH, Lee D, Curina C, Costantini M, Barbi S, Miao Y, Pellegrini M
- KMID: 2455080
- Clin Exp Vaccine Res.
- 2019 Jul;8(2):94-102.
- doi: 10.7774/cevr.2019.8.2.94
PURPOSE: Results from a post-marketing study to generate evidence on 1-year antibody persistence and safety following vaccination of infants from South Korea with the quadrivalent meningococcal conjugate vaccine MenACWY-CRM. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
